Pro-905 exhibits antitumor activity by delivering the active nucleotide antimetabolite thioguanosine monophosphate (TGMP) to tumors; it effectively inhibits the incorporation of purine salvage substrates into nucleic acids, suppresses colony formation of human malignant peripheral nerve sheath tumor (MPNST) cells, inhibits MPNST growth, and enhances the antitumor efficacy of JHU395 (HY-124778).